Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 210 of 210 entries
Sorted by: Best Match Show Resources per page
Functional and ultrastructural analysis of reafferent mechanosensation in larval zebrafish.

Current biology : CB

Odstrcil I, Petkova MD, Haesemeyer M, Boulanger-Weill J, Nikitchenko M, Gagnon JA, Oteiza P, Schalek R, Peleg A, Portugues R, Lichtman JW, Engert F.
PMID: 34822765
Curr Biol. 2021 Nov 17; doi: 10.1016/j.cub.2021.11.007. Epub 2021 Nov 17.

All animals need to differentiate between exafferent stimuli, which are caused by the environment, and reafferent stimuli, which are caused by their own movement. In the case of mechanosensation in aquatic animals, the exafferent inputs are water vibrations in...

Cite
Odstrcil I, Petkova MD, Haesemeyer M, et al. Functional and ultrastructural analysis of reafferent mechanosensation in larval zebrafish. Curr Biol. 2021;doi: 10.1016/j.cub.2021.11.007.
Odstrcil, I., Petkova, M. D., Haesemeyer, M., Boulanger-Weill, J., Nikitchenko, M., Gagnon, J. A., Oteiza, P., Schalek, R., Peleg, A., Portugues, R., Lichtman, J. W., & Engert, F. (2021). Functional and ultrastructural analysis of reafferent mechanosensation in larval zebrafish. Current biology : CB, . https://doi.org/10.1016/j.cub.2021.11.007
Odstrcil, Iris, et al. "Functional and ultrastructural analysis of reafferent mechanosensation in larval zebrafish." Current biology : CB vol. (2021). doi: https://doi.org/10.1016/j.cub.2021.11.007
Odstrcil I, Petkova MD, Haesemeyer M, Boulanger-Weill J, Nikitchenko M, Gagnon JA, Oteiza P, Schalek R, Peleg A, Portugues R, Lichtman JW, Engert F. Functional and ultrastructural analysis of reafferent mechanosensation in larval zebrafish. Curr Biol. 2021 Nov 17; doi: 10.1016/j.cub.2021.11.007. Epub 2021 Nov 17. PMID: 34822765.
Copy Download .nbib Format: NLM
Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis.

Ocular immunology and inflammation

Barton K, Hall AJ, Rosen PH, Cooling RJ, Lightman S.
PMID: 22823151
Ocul Immunol Inflamm. 1994;2(4):207-16. doi: 10.3109/09273949409057078.

Cataract remains difficult to manage in patients with uveitis affecting the posterior segment of the eye due to the high risk of postoperative complications, especially cystoid macular oedema, even in eyes in which inflammation has been completely suppressed preoperatively....

Cite
Barton K, Hall AJ, Rosen PH, et al. Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. Ocul Immunol Inflamm. 1994;2(4):207-16doi: 10.3109/09273949409057078.
Barton, K., Hall, A. J., Rosen, P. H., Cooling, R. J., & Lightman, S. (1994). Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. Ocular immunology and inflammation, 2(4), 207-16. https://doi.org/10.3109/09273949409057078
Barton, K, et al. "Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis." Ocular immunology and inflammation vol. 2,4 (1994): 207-16. doi: https://doi.org/10.3109/09273949409057078
Barton K, Hall AJ, Rosen PH, Cooling RJ, Lightman S. Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. Ocul Immunol Inflamm. 1994;2(4):207-16. doi: 10.3109/09273949409057078. PMID: 22823151.
Copy Download .nbib Format: NLM
Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status.

Journal of geriatric oncology

Jensen CE, Vohra SN, Nyrop KA, Deal AM, Muss HB, Lichtman EI, Rubinstein SM, Wood WA, Mangieri NJ, Jamison L, Grant SJ, Tuchman SA.
PMID: 34389255
J Geriatr Oncol. 2021 Aug 10; doi: 10.1016/j.jgo.2021.08.004. Epub 2021 Aug 10.

OBJECTIVES: Findings from a brief geriatric assessment (GA) in a cohort of adults with multiple myeloma (MM) are presented, with particular attention to the utility of the GA in identifying important deficits in adults judged to have a normal...

Cite
Jensen CE, Vohra SN, Nyrop KA, et al. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. J Geriatr Oncol. 2021;doi: 10.1016/j.jgo.2021.08.004.
Jensen, C. E., Vohra, S. N., Nyrop, K. A., Deal, A. M., Muss, H. B., Lichtman, E. I., Rubinstein, S. M., Wood, W. A., Mangieri, N. J., Jamison, L., Grant, S. J., & Tuchman, S. A. (2021). Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. Journal of geriatric oncology, . https://doi.org/10.1016/j.jgo.2021.08.004
Jensen, Christopher E, et al. "Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status." Journal of geriatric oncology vol. (2021). doi: https://doi.org/10.1016/j.jgo.2021.08.004
Jensen CE, Vohra SN, Nyrop KA, Deal AM, Muss HB, Lichtman EI, Rubinstein SM, Wood WA, Mangieri NJ, Jamison L, Grant SJ, Tuchman SA. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. J Geriatr Oncol. 2021 Aug 10; doi: 10.1016/j.jgo.2021.08.004. Epub 2021 Aug 10. PMID: 34389255.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in synaptic neuroscience

Rock EM, Limebeer CL, Sullivan MT, DeVuono MV, Lichtman AH, Di Marzo V, Mechoulam R, Parker LA.
PMID: 33767617
Front Synaptic Neurosci. 2021 Mar 09;13:620145. doi: 10.3389/fnsyn.2021.620145. eCollection 2021.

The endogenous amide

Cite
Rock EM, Limebeer CL, Sullivan MT, et al. . Front Synaptic Neurosci. 2021;13:620145doi: 10.3389/fnsyn.2021.620145.
Rock, E. M., Limebeer, C. L., Sullivan, M. T., DeVuono, M. V., Lichtman, A. H., Di Marzo, V., Mechoulam, R., & Parker, L. A. (2021). . Frontiers in synaptic neuroscience, 13620145. https://doi.org/10.3389/fnsyn.2021.620145
Rock, Erin M, et al. "." Frontiers in synaptic neuroscience vol. 13 (2021): 620145. doi: https://doi.org/10.3389/fnsyn.2021.620145
Rock EM, Limebeer CL, Sullivan MT, DeVuono MV, Lichtman AH, Di Marzo V, Mechoulam R, Parker LA. . Front Synaptic Neurosci. 2021 Mar 09;13:620145. doi: 10.3389/fnsyn.2021.620145. eCollection 2021. PMID: 33767617; PMCID: PMC7985545.
Copy Download .nbib Format: NLM
Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology.

The oncologist

Lichtman MA.
PMID: 34409677
Oncologist. 2021 Nov;26(11):906-909. doi: 10.1002/onco.13947. Epub 2021 Sep 12.

No abstract available.

Cite
Lichtman MA. Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology. Oncologist. 2021;26(11):906-909doi: 10.1002/onco.13947.
Lichtman, M. A. (2021). Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology. The oncologist, 26(11), 906-909. https://doi.org/10.1002/onco.13947
Lichtman, Marshall A. "Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology." The oncologist vol. 26,11 (2021): 906-909. doi: https://doi.org/10.1002/onco.13947
Lichtman MA. Minimally Deviated Lymphohematopoietic Neoplasms: Nomenclature in the Context of Pathobiology. Oncologist. 2021 Nov;26(11):906-909. doi: 10.1002/onco.13947. Epub 2021 Sep 12. PMID: 34409677; PMCID: PMC8571735.
Copy Download .nbib Format: NLM
The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

The Journal of pharmacology and experimental therapeutics

Dodu JC, Moncayo RK, Damaj MI, Schlosburg JE, Akbarali HI, O'Brien LD, Kendall DA, Wu Z, Lu D, Lichtman AH.
PMID: 34625464
J Pharmacol Exp Ther. 2022 Jan;380(1):1-14. doi: 10.1124/jpet.121.000723. Epub 2021 Oct 08.

Opioid use disorder reflects a major public health crisis of morbidity and mortality in which opioid withdrawal often contributes to continued use. However, current medications that treat opioid withdrawal symptoms are limited by their abuse liability or lack of...

Cite
Dodu JC, Moncayo RK, Damaj MI, et al. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice. J Pharmacol Exp Ther. 2021;380(1):1-14doi: 10.1124/jpet.121.000723.
Dodu, J. C., Moncayo, R. K., Damaj, M. I., Schlosburg, J. E., Akbarali, H. I., O'Brien, L. D., Kendall, D. A., Wu, Z., Lu, D., & Lichtman, A. H. (2022). The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice. The Journal of pharmacology and experimental therapeutics, 380(1), 1-14. https://doi.org/10.1124/jpet.121.000723
Dodu, Julien C, et al. "The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice." The Journal of pharmacology and experimental therapeutics vol. 380,1 (2022): 1-14. doi: https://doi.org/10.1124/jpet.121.000723
Dodu JC, Moncayo RK, Damaj MI, Schlosburg JE, Akbarali HI, O'Brien LD, Kendall DA, Wu Z, Lu D, Lichtman AH. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice. J Pharmacol Exp Ther. 2022 Jan;380(1):1-14. doi: 10.1124/jpet.121.000723. Epub 2021 Oct 08. PMID: 34625464.
Copy Download .nbib Format: NLM
Showing 205 to 210 of 210 entries